Covid-19 roundup: US lands another 100M-dose contract from J&J to back Biden's pledge; Pfizer and BioNTech could produce 3B vaccine doses next year

Nicole DeFeudis

Editor

John Carroll

Editor & Founder

With headlines around the globe focused on various hitches in the global supply chain for Covid vaccines, President Joe Biden is taking out an insurance …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: US lands another 100M-dose contract from J&J to back Biden's pledge; Pfizer and BioNTech could produce 3B vaccine doses next year

Nicole DeFeudis

Editor

John Carroll

Editor & Founder

Sign up to read this article for free.

Applied Therapeutics' rare disease drug gets a CRL

FDA is looking into hematology risks after patients take Bluebird's Skysona gene therapy

Novartis to cut 139 jobs in NJ as part of commercial refocus

PTC reports Phase 2 ALS fail, sells priority review voucher for $150M

To lead NIH, Trump taps Stanford academic and pandemic response critic Jay Bhattacharya

Advanz Pharma faces revocation of European authorization for liver disease drug Ocaliva

Covid-19 roundup: US lands an­oth­er 100M-dose con­tract from J&J to back Biden's pledge; Pfiz­er and BioN­Tech could pro­duce 3B vac­cine dos­es next year

Editor

Editor & Founder

Sign up to read this article for free.

more like this

Covid-19 roundup: US lands another 100M-dose contract from J&J to back Biden's pledge; Pfizer and BioNTech could produce 3B vaccine doses next year